Showing 2,676 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment side-effects

Vertex hepatitis C drug Incivek gets 'black box' warning over possible fatal skin conditions

Editor's pick
Washington Post
20 December 2012
New & experimental hepatitis C treatment

Hepatitis C - First Interferon-Free Regimens Expected to Launch in 2014 in the United States and Europe

Editor's pick
HCV New Drugs Research
19 December 2012
Cancer

Liver cancer has a more aggressive disease course in HIV-positive people co-infected with viral hepatitis

News
18 December 2012
Pharmaceutical industry

Breaking Up With Gilead Sciences

Editor's pick
The Street
17 December 2012
Hepatitis C transmission & prevention

Copy of HIV+ MSM have 4 times HCV risk of HIV-negative MSM in meta-analysis

Editor's pick
International AIDS Society
17 December 2012
Hepatitis C transmission & prevention

HIV+ MSM have 4 times HCV risk of HIV-negative MSM in meta-analysis

Editor's pick
International AIDS Society
17 December 2012
Hepatitis C transmission & prevention

HIV11: Sexually transmitted HCV rising among HIV+ gay men in Europe, but more are getting treated

Editor's pick
HIVandhepatitis.com
17 December 2012
Hepatitis C transmission & prevention

Hepatitis C Sexual Transmission Is Rare among Monogamous Heterosexual Couples

Editor's pick
HIVandhepatitis.com
17 December 2012
Hepatitis C treatment

Accessing Hepatitis C Patients Who Are Difficult to Reach

Editor's pick
Medscape (requires registration)
17 December 2012
Hepatitis C treatment

Though Hepatitis C Patients Report Having Equal Influence with Their Treating Physicians Regarding the Management and Treatment of Their Disease, Very Few Have Ever Requested Specific Products for Treatment

Editor's pick
Market Watch (press release)
13 December 2012
Hepatitis B

Adding pegylated interferon to entecavir improves hepatitis B treatment response

News
13 December 2012
Hepatitis C treatment

Adherence to hepatitis C treatment: unravelling the complexities

News
13 December 2012
Hepatitis C transmission & prevention

New NICE public health guidance aims to ensure more people at increased risk of hepatitis B and C infection are tested

Editor's pick
NICE
12 December 2012
Hepatitis C symptoms & diagnosis

Aging Hepatitis C Population Escalates Demand for Liver Transplantation

Editor's pick
Science Daily
12 December 2012
New & experimental hepatitis C treatment

Is a simple sofosbuvir plus ribavirin regimen suitable for difficult-to-treat hepatitis C patients?

News
12 December 2012
Hepatitis & HIV

HIV and hepatitis C co-infection increases the risk of cognitive impairment

News
11 December 2012
Pharmaceutical industry

Copy of ITPC Open letter from activists in EECA about the Galien Prix Award goint to Merck for boceprevir

Editor's pick
GMI Partnership
6 December 2012
Pharmaceutical industry

ITPC Open letter from activists in EECA about the Galien Prix Award goint to Merck for boceprevir

Editor's pick
EATG
6 December 2012
Side effects

Copy of Liver toxicity uncommon with modern antiretroviral drugs, but higher risk for HIV/HCV coinfected

Editor's pick
HIVandHepatitis.com
6 December 2012
Side effects

Liver toxicity uncommon with modern antiretroviral drugs, but higher risk for HIV/HCV coinfected

Editor's pick
HIVandHepatitis.com
6 December 2012
New & experimental hepatitis C treatment

Hepatitis C patients with cirrhosis respond well to boceprevir or telaprevir with careful monitoring

News
5 December 2012
Cancer

Brivanib fails to match sorafenib for liver cancer, but tivantinib looks promising

News
5 December 2012
New & experimental hepatitis C treatment

Monoclonal antibody GS-6624 well tolerated by patients with hepatic fibrosis in initial safety study

Editor's pick
Healio Hepatology
4 December 2012
New & experimental hepatitis C treatment

Telaprevir and VX-222 pair well in interferon-free regimen, VX-135 on the horizon

News
3 December 2012